News & Publications
Milestones, papers,
and press.
The public trail of what we've shipped and what we've learned. Papers include negative results — we publish those too.
01 · Recent
Recent updates.
2026 · 01 · 08
Milestone
Peptide modality development kicks off — cyclic and macrocyclic capabilities expected to enter discovery in 2026
→
2025 · 11 · 12
Milestone
drug.AI Platform v0.1 (Beta) released — reasoning graph and human-in-the-loop review gates go live across all agents
→
2025 · 08 · 27
Press
Dr. Dony Ang and Linna Makmura co-found Siloam Therapeutics to build agentic AI for rare-oncology drug discovery
→
02 · Publications
Selected papers.
Peer-reviewed publications and dissertation from our founding team — indexed on Google Scholar.
Pharmaceuticals · 2024
De novo drug design using transformer-based machine translation and reinforcement learning of an adaptive Monte Carlo tree search
Doctoral Dissertation · 2024
Advancement in in-silico drug discovery: from virtual screening and molecular dockings to de-novo drug design with transformer-based generative AI and reinforcement learning
Biology · 2023
Virtual and in vitro screening of natural products identifies indole and benzene derivatives as inhibitors of SARS-CoV-2 main protease (Mpro)
03 · Press
For press inquiries.
Journalists and analysts: reach us at info@siloamtherapeutics.com. We aim to respond within one business day.